Salvianolic acid C ameliorates ANIT-induced cholestatic liver injury by modulating bile acid metabolism, inflammation, and oxidative stress
Frontiers in Pharmacology · 19.11.2026 · 17
DOI: 10.3389/fphar.2026.1944361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.11.2026. Verfasst von Hongying Zhou und 6 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cholestatic liver injury (CLI) is characterized by the accumulation of toxic bile acids (BAs) and lacks effective therapeutic agents in clinical practice. Salvianolic acid C (SAC) is a hepatoprotective polyphenol, but its efficacy in treating BA metabolic disorders and the underlying mechanism remain unclear. We investigated the protective effect of SAC in α-naphthyl isothiocyanate (ANIT)-induced CLI in rats.
Methods
SAC (10, 20 mg/kg) was administered by gavage daily for 7 days, with ANIT administered by gavage on day 5.
Results
SAC improved liver function, attenuated hepatic oxidative stress and inflammation, and reduced necrosis and inflammatory infiltration. Serum BA profiling showed that SAC remodeled BA profiles, with changes in DCA, LCA, β-MCA, Tα-MCA, and UDCA-3S. Bio-layer interferometry (BLI) assays showed that SAC binds with favorable affinity to BA metabolism-related receptors (FXR, PPARα, and FGFR4). Western blotting and immunofluorescence further confirmed that SAC regulates the expression of these target proteins. In addition, SAC upregulated the protein levels of FXR, SHP, PPARα, FGFR4, BSEP, ABCB4, Nrf2, GPX4, and FTH1, while downregulating those of CYP7A1, CYP8B1, IL-6R, NF-κB p65, JAK2, STAT3, and HO-1, and reducing 4-HNE levels.
Discussion
These findings suggest that SAC protects against ANIT-induced CLI, possibly by regulating BA homeostasis, inflammatory responses, and oxidative stress.
Zitieren
APA
Zhou, H., Yang, J., Ma, X., Zhou, X., Wei, S., Zhao, Y., & Li, C. (2026). Salvianolic acid C ameliorates ANIT-induced cholestatic liver injury by modulating bile acid metabolism, inflammation, and oxidative stress. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1944361
Vancouver
Zhou H, Yang J, Ma X, Zhou X, Wei S, Zhao Y, et al. Salvianolic acid C ameliorates ANIT-induced cholestatic liver injury by modulating bile acid metabolism, inflammation, and oxidative stress. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1944361
BibTeX
@article{Zhou2026,
author = {Zhou, Hongying and Yang, Jie and Ma, Xiao and Zhou, Xuelin and Wei, Shizhang and Zhao, Yanling and Li, Chunyu},
title = {Salvianolic acid C ameliorates ANIT-induced cholestatic liver injury by modulating bile acid metabolism, inflammation, and oxidative stress},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1944361}
}
EUVIMED